Talcum Powder Cancer Lawsuit

Johnson's Baby Powder Imagery Should Have Been A Skull And Crossbones, Not a Smiling, Happy Baby

Mothers and other women were deceived by the babyface imagery on Johnson's Baby Powder packaging

Thursday, September 16, 2021 - Information is coming forward about the lengths Johnson & Johnson was willing to stoop to protect the stream they were earning from selling Johnson's Baby Powder. Credible reports by Reuters, CNN, NPR, and others allege that the company knew as early as 1971 that talc could contain asbestos and that asbestos was carcinogenic. Instead of placing a talcum powder cancer warning label alerting customers of the dangers of using talcum powder, the company decided to go all-in and amplify their marketing to mothers and their children. The legal community is watching the accusations made in a talcum powder lawsuit filed by the National Council of Negro Women. The lawsuit alleges the company deliberately targeted African American women with their talcum powder advertising, telling or implying that using Johnson's Baby Powder on their genitals would help them smell more "normal." According to NPR, "This company, through its words and images, told Black women that we were offensive in our natural state and needed to use their products to stay fresh, Janice Mathis, executive director of the National Council of Negro Women, in a statement."

According to Ms. Mathis, the advertising caused an entire generation of African American women and their daughters to make using Johnson's Baby Powder part of their everyday routine without warning them of the asbestos cancer dangers that lurked in every bottle of powder. The iconic smiling baby face image on Johnson's Baby Powder packaging is the same as if the company wrote that the product was so safe that it could be used on a baby. When Johnson & Johnson first became aware of the asbestos dangers in talcum powder they fought the Food and Drug Administration which attempted to force the cosmetics industry to adopt a more stringent asbestos testing method. Instead of using the methods that found asbestos in nearly every talc-based cosmetic product tested, the industry set an upper limit of 1% asbestos as being acceptable and within the designation of being cosmetics grade pure. Medical experts agree that no level of asbestos is safe. Even one microscopic particle inhaled or ingested through a mucous membrane could lead to cancer or mesothelioma.

Since the time of the Reuters investigation targeting Johnson & Johnson's nefarious handling of their asbestos talcum powder problem, the company has been hit with billions of dollars in jury awards and more than 30,000 pending lawsuits by women who claim using Johnson's Baby Powder for feminine hygiene cause them to develop ovarian cancer, a death sentence for most who are diagnosed with the disease. In 2020, Johnson & Johnson discontinued selling Baby Powder in North America, but continue to target women of color in India. Alex Gorsky, the company's CEO announced he is resigning under pressure from stockholders critical of his handling of the asbestos public relations nightmare. Johnson & Johnson has threatened to spin off their talcum powder business into a separate entitiy, and then bankrupt the new company to protect the parent company's $500 billion in assets, much of it earned from a century of baby powder sales while lying about the product's safety.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.